145 related articles for article (PubMed ID: 15155188)
1. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
Bland MV; Ismail S; Heinemann JA; Keenan JI
Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
[TBL] [Abstract][Full Text] [Related]
3. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
[TBL] [Abstract][Full Text] [Related]
4. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.
Marcus EA; Sachs G; Scott DR
Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858
[TBL] [Abstract][Full Text] [Related]
5. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
Vogt K; Rodloff AC; Hahn H
Infection; 1991; 19(3):138-9. PubMed ID: 1832417
[TBL] [Abstract][Full Text] [Related]
6. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
Alarcón T; Domingo D; Prieto N; López-Brea M
Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
[TBL] [Abstract][Full Text] [Related]
7. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
[TBL] [Abstract][Full Text] [Related]
8. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.
Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA
Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405
[TBL] [Abstract][Full Text] [Related]
9. Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.
Sandha GS; LeBlanc R; Van Zanten SJ; Sitland TD; Agocs L; Burford N; Best L; Mahoney D; Hoffman P; Leddin DJ
Dig Dis Sci; 1998 Dec; 43(12):2727-32. PubMed ID: 9881506
[TBL] [Abstract][Full Text] [Related]
10. Siderophore production and iron-regulated envelope proteins of Helicobacter pylori.
Illingworth DS; Walter KS; Griffiths PL; Barclay R
Zentralbl Bakteriol; 1993 Sep; 280(1-2):113-9. PubMed ID: 8280932
[TBL] [Abstract][Full Text] [Related]
11. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
Shaikh AR; Giridhar R; Megraud F; Yadav MR
Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
[TBL] [Abstract][Full Text] [Related]
12. Selective and effective bactericidal activity of the cobalt (II) cation against Helicobacter pylori.
Bruggraber SF; French G; Thompson RP; Powell JJ
Helicobacter; 2004 Oct; 9(5):422-8. PubMed ID: 15361081
[TBL] [Abstract][Full Text] [Related]
13. Bismuth-Induced Inactivation of Ferric Uptake Regulator from Helicobacter pylori.
He X; Liao X; Li H; Xia W; Sun H
Inorg Chem; 2017 Dec; 56(24):15041-15048. PubMed ID: 29200284
[TBL] [Abstract][Full Text] [Related]
14. Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions.
Mobley HL; Garner RM; Chippendale GR; Gilbert JV; Kane AV; Plaut AG
Helicobacter; 1999 Sep; 4(3):162-9. PubMed ID: 10469190
[TBL] [Abstract][Full Text] [Related]
15. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
[TBL] [Abstract][Full Text] [Related]
16. Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts.
Stratton CW; Warner RR; Coudron PE; Lilly NA
J Antimicrob Chemother; 1999 May; 43(5):659-66. PubMed ID: 10382887
[TBL] [Abstract][Full Text] [Related]
17. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H
J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094
[TBL] [Abstract][Full Text] [Related]
18. The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia.
Lee JH; Choe YH; Choi YO
Helicobacter; 2009 Feb; 14(1):36-9. PubMed ID: 19191894
[TBL] [Abstract][Full Text] [Related]
19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
20. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
